Colour doppler studies of axillary node metastases in breast carcinoma

Walsh, J.S.; Dixon, JM; Chetty, U.; Paterson, Daniel

doi:10.1016/s0009-9260(05)81774-x

Cited by 45 publications

(18 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These results are comparable to findings in CT examinations of the axilla but are poorer than results from ultrasound examinations of the axillary content [12,31,32]. The chosen size threshold between normal and enlarged axillary lymph nodes varies in different studies between 0.5 and 1.0 cm in diameter, and short-axis measurements of the lymph nodes have been the most common practice [10,11,12].…”

Section: Discussionsupporting

confidence: 56%

Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI

et al. 2000

View full text Add to dashboard Cite

Metastatic involvement of axillary lymph nodes is one of the most important prognostic variables in breast cancer. The aim of our work was to study the value of dynamic contrast-enhanced MR imaging in revealing axillary lymph node metastases from breast cancer. A total of 65 patients with invasive breast cancer treated with axillary lymph node dissection were preoperatively evaluated by MRI. T1-weighted dynamic contrast-enhanced 3D images were acquired using a coil covering the breast and the axilla. The dynamic contrast enhancement, size, and morphology of the axillary lymph nodes were registered. Histopathological examination revealed axillary lymph node metastases in 24 patients. When using a signal intensity increase in the lymph nodes of >100% during the first postcontrast image as a threshold for malignancy, 57 of 65 patients were correctly classified (sensitivity 83%, specificity 90%, accuracy 88%). These results were not improved when lymph node size and morphology were used as additional criteria. Axillary lymph nodes can be evaluated as a part of an MR-mammography study without substantial increase in examination time, and provide the surgeon with knowledge about the localization of possible metastatic lymph nodes.

show abstract

Section: Discussionsupporting

confidence: 56%

Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI

et al. 2000

View full text Add to dashboard Cite

show abstract

“…[6][7][8] We suspected that the sensitivity of ultrasound was higher than previously published indications, provided that optimal transducers, updated electronics, and very experienced sonographers were used. We, therefore, decided to conduct a prospective study.…”

Section: Introductionmentioning

confidence: 98%

Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: A prospective study in 144 consecutive patients

Verbanck

Vandewiele

Winter

et al. 1997

J. Clin. Ultrasound

View full text Add to dashboard Cite

“…To our knowledge, there is only one study in which color Doppler flow has been addressed as a diagnostic criterion for axillary nodal metastasis (20). However, no formal evaluation of the color Doppler US characteristics of axillary lymph nodes was performed in this earlier study.…”

mentioning

confidence: 95%

Patients with Breast Cancer: Differences in Color Doppler Flow and Gray-Scale US Features of Benign and Malignant Axillary Lymph Nodes

Yang¹,

Chang‐Claude²,

Metrewell³

2000

Radiology

166

View full text Add to dashboard Cite

show abstract

Colour doppler studies of axillary node metastases in breast carcinoma

Cited by 45 publications

References 17 publications

Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI

Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI

Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: A prospective study in 144 consecutive patients

Patients with Breast Cancer: Differences in Color Doppler Flow and Gray-Scale US Features of Benign and Malignant Axillary Lymph Nodes

Contact Info

Product

Resources

About